(Q33599884)

28 July 2017

Low molecular weight protamine: a potential nontoxic heparin antagonist (English)

1 reference

28 July 2017

1 reference

Byun Y

1

1 reference

PubMed ID

10213181

28 July 2017

Singh VK

series ordinal

2

1 reference

PubMed ID

10213181

28 July 2017

Yang VC

series ordinal

3

1 reference

28 July 2017

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

94

1 reference

28 July 2017

1

1 reference

28 July 2017

53-61

1 reference

Serious adverse reactions to protamine sulfate: are alternatives needed?

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Protamine sulphate: a review of its effects: hypersensitivity and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Antigenicity: Some Molecular Aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Electrochemical sensor for heparin: further characterization and bioanalytical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Detection of circulating immune complexes by a C1q-microplate ELISA system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Molecular modeling of protein-glycosaminoglycan interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

Interaction of protamine sulfate with thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

The Use of Immobilized Protamine in Removing Heparin and Preventing Protamine-induced Complications during Extracorporeal Blood Circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900201-1

7 January 2021

10.1016/S0049-3848(98)00201-1

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10213181